p.71 抽出テキスト

for ventricular tachycardia in repaired Tetralogy of Fallot. Eur Heart J 2017; 38: 268-276. PMID: 28182233 88. Sandhu A, Ruckdeschel E, Sauer WH, et al. Perioperative electrophysiology study in patients with tetralogy of Fallot undergoing pulmonary valve replacement will identify those at high risk of subsequent ventricular tachycardia. Heart Rhythm 2018; 15: 679-685. PMID: 29330130 89. Yoshinaga M, Ushinohama H, Sato S, et al. Electrocardiographic screening of 1-month-old infants for identifying prolonged QT intervals. Circ Arrhythm Electrophysiol 2013; 6: 932-938. PMID: 24036083 90. Hayashi K, Fujino N, Uchiyama K, et al. Long QT syndrome and associated gene mutation carriers in Japanese children: results from ECG screening examinations. Clin Sci (Lond) 2009; 117: 415-424. PMID: 19371231 91. Schwartz PJ, Stramba-Badiale M, Crotti L, et al. Prevalence of the congenital long-QT syndrome. Circulation 2009; 120: 1761-1767. PMID: 19841298 92. Wilde AAM, Semsarian C, Márquez MF, et al. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases. J Arrhythm 2022; 38: 491-553. PMID: 35936045 93. 鈴木博.遺伝性不整脈の診断と治療:QT延長症候群,QT 短縮症候群,CPVT,Brugada 症候群について.日小循誌 2019;35: 249-263. 94. Aziz PF, Wieand TS, Ganley J, et al. Genotype- and mutation site-specific QT adaptation during exercise, recovery, and postural changes in children with long-QT syndrome. Circ Arrhythm Electrophysiol 2011; 4: 867-873. PMID: 21956039 95. Takenaka K, Ai T, Shimizu W, et al. Exercise stress test amplifies genotype-phenotype correlation in the LQT1 and LQT2 forms of the long-QT syndrome. Circulation 2003; 107: 838-844. PMID: 12591753 96. Shimizu W, Noda T, Takaki H, et al. Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome. Heart Rhythm 2004; 1: 276-283. PMID: 15851169 97. 日本循環器学会,日本心臓病学会,日本小児循環器学会.2024年改訂版 心臓血管疾患における遺伝学的検査と遺伝カウンセリングに関するガイドライン.https://www.j-circ.or.jp/cms/wp-content/ uploads/2024/03/JCS2024_Imai.pdf 98. Schwartz PJ, Crotti L. QTc behavior during exercise and genetic testing for the long-QT syndrome. Circulation 2011; 124: 2181-2184. PMID: 22083145 99. Priori SG, Wilde AA, Horie M, et al. Executive summary: HRS/ EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Heart Rhythm 2013; 10: e85-e108. PMID: 23916535 100. Tobert KE, Bos JM, Garmany R, et al. Return-to-Play for Athletes With Long QT Syndrome or Genetic Heart Diseases Predisposing to Sudden Death. J Am Coll Cardiol 2021; 78: 594-604. PMID: 34330632 101. Davydoff C, Andorin A, Minois D, et al. Does sports participation increase risk in patients with long QT syndrome? Results from a large French cohort. Europace 2022; 24: 1675-1683. PMID: 35951747 102. Pelliccia A, Sharma S, Gati S, et al. ESC Scientific Document Group. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. Eur Heart J 2021; 42: 17-96. PMID: 32860412 103. Heidbuchel H, Arbelo E, D'Ascenzi F, et al. Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions. Part 2: ventricular arrhythmias, channelopathies, and implantable defibrillators. Europace 2021; 23: 147-148. PMID: 32596731 104. Lampert R, Day S, Ainsworth B, et al. Vigorous Exercise in Patients With Congenital Long QT Syndrome: Results of the Prospective, Observational, Multinational LIVE-LQTS Study. Circulation 2024; 150: 516-530. PMID: 39051104 105. Priori SG, Schwartz PJ, Napolitano C, et al. Risk stratification in the long-QT syndrome. N Engl J Med 2003; 348: 1866-1874. PMID: 12736279 106. Ozawa J, Ohno S, Hisamatsu T, et al. Pediatric Cohort With Long QT Syndrome KCNH2 Mutation Carriers Present Late Onset But Severe Symptoms. Circ J 2016; 80: 696-702. PMID: 26823142 107. Shimizu W, Moss AJ, Wilde AA, et al. Genotype-phenotype aspects of type 2 long QT syndrome. J Am Coll Cardiol 2009; 54: 2052-2062. PMID: 19926013 108. 日本循環器学会.遺伝性不整脈の診療に関するガイドライン(2017

年改訂版).https://www.j-circ.or.jp/cms/wp-content/uploads/2017/12/ JCS2017_aonuma_h.pdf 109. 日本循環器学会,日本不整脈心電学会.2020年改訂版 不整脈薬物

治療ガイドライン.https://www.j-circ.or.jp/cms/wp-content/ uploads/2020/01/JCS2020_Ono.pdf 110. Finocchiaro G, Westaby J, Sheppard MN, et al. Sudden Cardiac Death in Young Athletes: JACC State-of-the-Art Review. J Am Coll Cardiol 2024; 83: 350-370. PMID: 38199713 111. Napolitano C, Mazzanti A, Bloise R, et al. Catecholaminergic Polymorphic Ventricular Tachycardia. GeneReviews®. October 14, 2004 (Last Update: June 23, 2022). 112. Bai R, Napolitano C, Bloise R, et al. Yield of genetic screening in inherited cardiac channelopathies: How to prioritize access to genetic testing. Circ Arrhythm Electrophysiol 2009; 2: 6-15. PMID: 19808439 113. Walsh R, Adler A, Amin AS, et al. Evaluation of gene validity for CPVT and short QT syndrome in sudden arrhythmic death. Eur Heart J 2022; 43: 1500-1510. PMID: 34557911 114. Roston TM, Vinocur JM, Maginot KR, et al. Catecholaminergic polymorphic ventricular tachycardia in children: analysis of therapeutic strategies and outcomes from an international multicenter registry. Circ Arrhythm Electrophysiol 2015; 8: 633-642. PMID: 25713214 115. Ozawa J, Ohno S, Fujii Y, et al. Differential Diagnosis Between Catecholaminergic Polymorphic Ventricular Tachycardia and Long QT Syndrome Type 1 Modified Schwartz Score. Circ J 2018; 82: 2269-2276. PMID: 29925740 116. Sy RW, Gollob MH, Klein GJ, et al. Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 2011; 8: 864-871. PMID: 21315846 117. Marjamaa A, Hiippala A, Arrhenius B, et al. Intravenous epinephrine infusion test in diagnosis of catecholaminergic polymorphic ventricular tachycardia. J Cardiovasc Electrophysiol 2012; 23: 194-199. PMID: 21954897 118. Ohno S, Omura M, Kawamura M, et al. Exon 3 deletion of RYR2 encoding cardiac ryanodine receptor is associated with left ventricular non-compaction. Europace 2014; 16: 1646-1654. PMID: 24394973 119. Nozaki Y, Kato Y, Uike K, et al. Co-Phenotype of Left Ventricular Non-Compaction Cardiomyopathy and Atypical Catecholaminergic Polymorphic Ventricular Tachycardia in Association With R169Q, a Ryanodine Receptor Type 2 Missense Mutation. Circ J 2020; 84: 226- 234. PMID: 31875585 120. Inoue YY, Aiba T, Kawata H, et al. Different responses to exercise between Andersen-Tawil syndrome and catecholaminergic polymorphic ventricular tachycardia. Europace 2018; 20: 1675-1682. PMID: 29309601 121. Shimamoto K, Ohno S, Kato K, et al. Impact of cascade screening for catecholaminergic polymorphic ventricular tachycardia type 1. Heart 2022; 108: 840-847. PMID: 35135837 122. Bjerregaard P. Diagnosis and management of short QT syndrome. Heart Rhythm 2018; 15: 1261-1267. PMID: 29501667 123. Suzuki H, Horie M, Ozawa J, et al. Novel electrocardiographic criteria for short QT syndrome in children and adolescents. Europace 2021; 23: 2029-2038. PMID: 34179980 124. Watanabe H, Makiyama T, Koyama T, et al. High prevalence of early repolarization in short QT syndrome. Heart Rhythm 2010; 7: 647- 652. PMID: 20206319 125. Anttonen O, Junttila MJ, Maury P, et al. Differences in twelve-lead electrocardiogram between symptomatic and asymptomatic subjects with short QT interval. Heart Rhythm 2009; 6: 267-271. PMID: 19187923 126. Giustetto C, Scrocco C, Schimpf R, et al. Usefulness of exercise test in the diagnosis of short QT syndrome. Europace 2015; 17: 628-634. PMID: 25833882 127. Tülümen E, Giustetto C, Wolpert C, et al. PQ segment depression in patients with short QT syndrome: a novel marker for diagnosing short QT syndrome? Heart Rhythm 2014; 11: 1024-1030. PMID: 24589867 128. Roussel J, Labarthe F, Thireau J, et al. Carnitine deficiency induces a short QT syndrome. Heart Rhythm 2016; 13: 165-174. PMID: 26190315 129. Gollob MH, Redpath CJ, Roberts JD. The short QT syndrome: proposed diagnostic criteria. J Am Coll Cardiol 2011; 57: 802-812. PMID: 21310316 130. Schwartz PJ, Ackerman MJ, George AL Jr, et al. Impact of genetics on the clinical management of channelopathies. J Am Coll Cardiol 2013; 62: 169-180. PMID: 23684683 131. Peltenburg PJ, Blom NA, Vink AS, et al. In Children and Adolescents From Brugada Syndrome-Families, Only SCN5A Mutation Carriers Develop a Type-1 ECG Pattern Induced By Fever. Circulation 2020; 142: 89-91. PMID: 32628552 132. Yamagata K, Horie M, Aiba T, et al. Genotype-Phenotype Correlation

of SCN5A Mutation for the Clinical and Electrocardiographic Characteristics of Probands With Brugada Syndrome: A Japanese Multi-